Patents by Inventor Xiaoping Du

Xiaoping Du has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10767959
    Abstract: The present invention relates to a recoil reduction air gun and a method of reducing recoil of air guns when discharging. Said recoil reduction air gun comprises a cylinder that is slidably mounted to a main body of said air gun, and a recoil reduction device that is provided between the cylinder and a stock. Said recoil reduction device further comprises a recoil reduction spring seat, a first and a second springs, and a recoil rod.
    Type: Grant
    Filed: December 29, 2015
    Date of Patent: September 8, 2020
    Assignee: XISICO USA, INC
    Inventors: Xiaoping Ji, Yecheng Wu, Xiaoqiang Sheng, Shengping Zeng, Fuying Ji, Ye Sun, Chengxin Du
  • Patent number: 10738080
    Abstract: Provided herein are compounds that inhibit a binding interaction between a ? integrin and a G protein subunit, as well as compositions, e.g., pharmaceutical compositions, comprising the same, and related kits. In some embodiments, the compound is an antibody or antibody analog, and, in other embodiments, the compound is a peptide or peptide analog. Also provided are methods of using the compounds, including methods of treating or preventing a medical condition, such as stroke, heart attack, cancer, or inflammation.
    Type: Grant
    Filed: May 22, 2018
    Date of Patent: August 11, 2020
    Assignee: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
    Inventor: Xiaoping Du
  • Patent number: 10391479
    Abstract: The present disclosure provides a hydrocracking catalyst, a method for preparing the same and a use of the same, and a method for hydrocracking catalytic diesel oil. The catalyst comprises a support, an active metal component, and carbon, wherein, based on the total weight of the catalyst, the content of the support is 60 to 90 wt %, the content of the active metal component calculated in metal oxides is 15 to 40 wt %, and the content of carbon calculated in C element is 1 to 5 wt %; measured with an infrared acidimetric estimation method, the acid properties of the hydrocracking catalyst are: the total infrared acid amount is 0.4 to 0.8 mmol/g, wherein, the infrared acid amount of strong acid with desorption temperature greater than 350° C. is 0.08 mmol/g or lower, and the ratio of the total infrared acid amount to the infrared acid amount of strong acid with desorption temperature greater than 350° C. is 5 to 50.
    Type: Grant
    Filed: November 11, 2016
    Date of Patent: August 27, 2019
    Assignees: China Petroleum & Chemical Corporation, Fushun Research Institute of Petroleum and Petrochemicals, SINOPEC CORP.
    Inventors: Wei Liu, YanZe Du, Bo Qin, FengLai Wang, XiaoPing Zhang, Hang Gao
  • Publication number: 20190169708
    Abstract: A press hardening steel by a medium and thin slab casting and direct rolling has a tensile strength 1900 MPa or more. The press hardening steel includes following chemical components by weight percent: C: 0.31-0.40%, Si: 0.36-0.44%, Mn: 1.6-2.0%, P?0.006%, S?0.004%, Als: 0.015-0.060%, Cr: 0.36-0.49%, Ti: 0.036-0.045% or Nb: 0.036-0.045% or V: 0.036-0.045%, or a mixture of the above two or more in any ratio, B: 0.004-0.005%, Mo: 0.26-0.35%, Ni: 0.11-0.20%, and N?0.005%. A method for producing the press hardening steel includes following steps: desulphurizing molten iron; electric furnace or converter smelting and refining; continuous casting; descaling treatment before entering a soaking furnace; heating and soaking; high-pressure water descaling before entering a rolling mill; hot rolling; cooling; coiling; austenitizing; die deforming and quenching.
    Type: Application
    Filed: August 1, 2017
    Publication date: June 6, 2019
    Applicant: WUHAN IRON AND STEEL COMPANY LIMITED
    Inventors: Xinping MAO, Shuize WANG, Kuanhui HU, Libo PAN, Rui GE, Lijun LI, Tao PENG, Xiaoping DUAN, Xiaofeng DU
  • Publication number: 20190023740
    Abstract: Provided herein are compounds that inhibit a binding interaction between a ? integrin and a G protein subunit, as well as compositions, e.g., pharmaceutical compositions, comprising the same, and related kits. In some embodiments, the compound is an antibody or antibody analog, and, in other embodiments, the compound is a peptide or peptide analog. Also provided are methods of using the compounds, including methods of treating or preventing a medical condition, such as stroke, heart attack, cancer, or inflammation.
    Type: Application
    Filed: May 22, 2018
    Publication date: January 24, 2019
    Inventor: Xiaoping Du
  • Patent number: 10011634
    Abstract: Provided herein are compounds that inhibit a binding interaction between a ? integrin and a G protein subunit, as well as compositions, e.g., pharmaceutical compositions, comprising the same, and related kits. In some embodiments, the compound is an antibody or antibody analog, and, in other embodiments, the compound is a peptide or peptide analog. Also provided are methods of using the compounds, including methods of treating or preventing a medical condition, such as stroke, heart attack, cancer, or inflammation.
    Type: Grant
    Filed: September 2, 2015
    Date of Patent: July 3, 2018
    Assignee: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
    Inventor: Xiaoping Du
  • Publication number: 20160257711
    Abstract: Provided herein are compounds that inhibit a binding interaction between a ? integrin and a G protein subunit, as well as compositions, e.g., pharmaceutical compositions, comprising the same, and related kits. In some embodiments, the compound is an antibody or antibody analog, and, in other embodiments, the compound is a peptide or peptide analog. Also provided are methods of using the compounds, including methods of treating or preventing a medical condition, such as stroke, heart attack, cancer, or inflammation.
    Type: Application
    Filed: September 2, 2015
    Publication date: September 8, 2016
    Inventor: Xiaoping Du
  • Patent number: 9156884
    Abstract: Provided herein are compounds that inhibit a binding interaction between a ? integrin and a G protein subunit, as well as compositions, e.g., pharmaceutical compositions, comprising the same, and related kits. In some embodiments, the compound is an antibody or antibody analog, and, in other embodiments, the compound is a peptide or peptide analog. Also provided are methods of using the compounds, including methods of treating or preventing a medical condition, such as stroke, heart attack, cancer, or inflammation.
    Type: Grant
    Filed: February 10, 2014
    Date of Patent: October 13, 2015
    Assignee: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
    Inventor: Xiaoping Du
  • Publication number: 20140228295
    Abstract: Provided herein are compounds that inhibit a binding interaction between a ? integrin and a G protein subunit, as well as compositions, e.g., pharmaceutical compositions, comprising the same, and related kits. In some embodiments, the compound is an antibody or antibody analog, and, in other embodiments, the compound is a peptide or peptide analog. Also provided are methods of using the compounds, including methods of treating or preventing a medical condition, such as stroke, heart attack, cancer, or inflammation.
    Type: Application
    Filed: February 10, 2014
    Publication date: August 14, 2014
    Applicant: The Board of Trustees of The University of Illinois
    Inventor: Xiaoping Du
  • Patent number: 8685921
    Abstract: Provided herein are compounds that inhibit a binding interaction between a ? integrin and a G protein subunit, as well as compositions, e.g., pharmaceutical compositions, comprising the same, and related kits. In some embodiments, the compound is an antibody or antibody analog, and, in other embodiments, the compound is a peptide or peptide analog. Also provided are methods of using the compounds, including methods of treating or preventing a medical condition, such as stroke, heart attack, cancer, or inflammation.
    Type: Grant
    Filed: September 15, 2012
    Date of Patent: April 1, 2014
    Assignee: The Board of Trustees of the University of Illinois
    Inventor: Xiaoping Du
  • Patent number: 8563690
    Abstract: Methods and compositions for inhibition of platelet cell aggregation are described. In particular, compositions comprising cell permeant RGT peptides, such as RGT bound to a lipid moiety are provided. Compositions may be used in the treatment and prevention of clot related diseases such as stroke and myocardial infarction.
    Type: Grant
    Filed: November 3, 2009
    Date of Patent: October 22, 2013
    Assignee: The Board of Trustees of the University of Illinois
    Inventors: Xiaoping Du, Xiaodong Xi
  • Publication number: 20130072433
    Abstract: Provided herein are compounds that inhibit a binding interaction between a ? integrin and a G protein subunit, as well as compositions, e.g., pharmaceutical compositions, comprising the same, and related kits. In some embodiments, the compound is an antibody or antibody analog, and, in other embodiments, the compound is a peptide or peptide analog. Also provided are methods of using the compounds, including methods of treating or preventing a medical condition, such as stroke, heart attack, cancer, or inflammation.
    Type: Application
    Filed: September 15, 2012
    Publication date: March 21, 2013
    Applicant: The Board of Trustees of the University of Illinois
    Inventor: Xiaoping Du
  • Patent number: 8173595
    Abstract: The present invention is directed to anti-platelet peptides that may be used in various methods for the treatment or prophylaxis of thrombosis. More specifically, the specification describes methods and compositions for making and using compositions GPIb? fragments as anti-platelet agents. The present invention is also directed to peptides that inhibit intracellular function of 14-3-3.
    Type: Grant
    Filed: April 27, 2005
    Date of Patent: May 8, 2012
    Assignee: The Board of Trustees of the University of Illinois
    Inventors: Kesheng Dai, Xiaoping Du
  • Publication number: 20100260828
    Abstract: Methods and compositions for inhibition of platelet cell aggregation are described. In particular, compositions comprising cell permeant RGT peptides, such as RGT bound to a lipid moiety are provided. Compositions may be used in the treatment and prevention of clot related diseases such as stroke and myocardial infarction.
    Type: Application
    Filed: November 3, 2009
    Publication date: October 14, 2010
    Applicant: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
    Inventors: Xiaoping Du, Xiaodong Xi
  • Publication number: 20090181057
    Abstract: The present invention is directed to compositions comprising inhibitors of GPIb-IX-VWF binding and methods of treating or preventing thrombosis associated with sepsis or endotoxemia in a mammal.
    Type: Application
    Filed: January 15, 2009
    Publication date: July 16, 2009
    Applicant: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
    Inventor: Xiaoping Du
  • Publication number: 20080293628
    Abstract: The present invention is directed to anti-platelet peptides that may be used in various methods for the treatment or prophylaxis of thrombosis. More specifically, the specification describes methods and compositions for making and using compositions GPIb? fragments as anti-platelet agents. The present invention is also directed to peptides that inhibit intracellular function of 14-3-3.
    Type: Application
    Filed: April 27, 2005
    Publication date: November 27, 2008
    Inventors: Kesheng Dai, Xiaoping Du
  • Publication number: 20040087539
    Abstract: Methods of treating thrombotic and hemostatic conditions related to platelet activity are described herein. The methods of treating thrombotic and hemostatic conditions use active agents that modulate production of guanosine 3′, 5′ cyclic monophosphate (cGMP) or the function of cGMP-dependent protein kinase (PKG), and its downstream effectors, the ERK and p38 pathways.
    Type: Application
    Filed: December 12, 2003
    Publication date: May 6, 2004
    Inventor: Xiaoping Du